Patents by Inventor Jens Walter

Jens Walter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240182522
    Abstract: A method of treating a patient who has glioblastoma and/or gastric cancer includes administering to said patient a composition containing a population of activated T cells that selectively recognize cells in the patient that aberrantly express a peptide. A pharmaceutical composition contains activated T cells that selectively recognize cells in a patient that aberrantly express a peptide, and a pharmaceutically acceptable carrier, in which the T cells bind to the peptide in a complex with an MHC class I molecule, and the composition is for treating the patient who has glioblastoma and/or gastric cancer. A method of treating a patient who has glioblastoma and/or gastric cancer includes administering to said patient a composition comprising a peptide in the form of a pharmaceutically acceptable salt, thereby inducing a T-cell response to the glioblastoma and/or gastric cancer.
    Type: Application
    Filed: January 5, 2024
    Publication date: June 6, 2024
    Inventors: Toni WEINSCHENK, Steffen WALTER, Jens FRITSCHE, Colette SONG, Harpreet SINGH
  • Patent number: 11975042
    Abstract: A pharmaceutical composition contains an antibody or a fragment thereof specific for COL6A3 for the treatment of a cancer. A method of treating a cancer includes administering to a subject in need thereof the pharmaceutical composition. A kit includes a container that contains the pharmaceutical composition. A method of producing an antibody or a fragment thereof against a peptide or a MHC/peptide complex. A method for detecting a diseased tissue includes administering to a subject in need thereof an antibody or a fragment thereof conjugated to a radioisotope and detecting a signal from the radioisotope in the subject. A method for treating a diseased tissue includes administering to a subject in need thereof an antibody or a fragment thereof conjugated to a toxin.
    Type: Grant
    Filed: July 23, 2021
    Date of Patent: May 7, 2024
    Assignee: Immatics Biotechnologies GmbH
    Inventors: Jens Fritsche, Toni Weinschenk, Steffen Walter, Peter Lewandrowski, Harpreet Singh
  • Patent number: 11969455
    Abstract: A pharmaceutical composition contains an antibody or a fragment thereof specific for COL6A3 for the treatment of a cancer. A method of treating a cancer includes administering to a subject in need thereof the pharmaceutical composition. A kit includes a container that contains the pharmaceutical composition. A method of producing an antibody or a fragment thereof against a peptide or a MHC/peptide complex. A method for detecting a diseased tissue includes administering to a subject in need thereof an antibody or a fragment thereof conjugated to a radioisotope and detecting a signal from the radioisotope in the subject. A method for treating a diseased tissue includes administering to a subject in need thereof an antibody or a fragment thereof conjugated to a toxin.
    Type: Grant
    Filed: June 25, 2021
    Date of Patent: April 30, 2024
    Assignee: Immatics Biotechnologies GmbH
    Inventors: Jens Fritsche, Toni Weinschenk, Steffen Walter, Peter Lewandrowski, Harpreet Singh
  • Patent number: 11957730
    Abstract: A pharmaceutical composition contains an antibody or a fragment thereof specific for COL6A3 for the treatment of a cancer. A method of treating a cancer includes administering to a subject in need thereof the pharmaceutical composition. A kit includes a container that contains the pharmaceutical composition. A method of producing an antibody or a fragment thereof against a peptide or a MHC/peptide complex. A method for detecting a diseased tissue includes administering to a subject in need thereof an antibody or a fragment thereof conjugated to a radioisotope and detecting a signal from the radioisotope in the subject. A method for treating a diseased tissue includes administering to a subject in need thereof an antibody or a fragment thereof conjugated to a toxin.
    Type: Grant
    Filed: July 23, 2021
    Date of Patent: April 16, 2024
    Inventors: Jens Fritsche, Toni Weinschenk, Steffen Walter, Peter Lewandrowski, Harpreet Singh
  • Patent number: 11939401
    Abstract: A method of treating a patient who has glioblastoma and/or gastric cancer includes administering to said patient a composition containing a population of activated T cells that selectively recognize cells in the patient that aberrantly express a peptide. A pharmaceutical composition contains activated T cells that selectively recognize cells in a patient that aberrantly express a peptide, and a pharmaceutically acceptable carrier, in which the T cells bind to the peptide in a complex with an MHC class I molecule, and the composition is for treating the patient who has glioblastoma and/or gastric cancer. A method of treating a patient who has glioblastoma and/or gastric cancer includes administering to said patient a composition comprising a peptide in the form of a pharmaceutically acceptable salt, thereby inducing a T-cell response to the glioblastoma and/or gastric cancer.
    Type: Grant
    Filed: March 18, 2022
    Date of Patent: March 26, 2024
    Assignee: Immatics Biotechnologies GmbH
    Inventors: Toni Weinschenk, Steffen Walter, Jens Fritsche, Colette Song, Harpreet Singh
  • Patent number: 11939400
    Abstract: A method of treating a patient who has glioblastoma and/or gastric cancer includes administering to said patient a composition containing a population of activated T cells that selectively recognize cells in the patient that aberrantly express a peptide. A pharmaceutical composition contains activated T cells that selectively recognize cells in a patient that aberrantly express a peptide, and a pharmaceutically acceptable carrier, in which the T cells bind to the peptide in a complex with an WIC class I molecule, and the composition is for treating the patient who has glioblastoma and/or gastric cancer. A method of treating a patient who has glioblastoma and/or gastric cancer includes administering to said patient a composition comprising a peptide in the form of a pharmaceutically acceptable salt, thereby inducing a T-cell response to the glioblastoma and/or gastric cancer.
    Type: Grant
    Filed: March 10, 2022
    Date of Patent: March 26, 2024
    Assignee: Immatics Biotechnologies GmbH
    Inventors: Toni Weinschenk, Steffen Walter, Jens Fritsche, Colette Song, Harpreet Singh
  • Publication number: 20230248787
    Abstract: Methods and compositions for a probiotic strain selected by targeted in vivo (in the human gut) enrichment to aid with healthy lactose digestion are provided. The probiotic strain selected may beneficially include Bifidobacterium adolescentis strain IVS-1 for reducing and/or preventing symptoms of lactose intolerance in a subject in need thereof.
    Type: Application
    Filed: February 2, 2023
    Publication date: August 10, 2023
    Inventors: Jens Walter, Zachery Lewis, Thomas Auchtung
  • Publication number: 20230146454
    Abstract: Lactobacillus reuteri strain having NCIMB accession number 42835 is from a novel phylogenetic clade and has unique immune-stimulatory properties and enhanced ecological performance in the human gut. A substrate for the strain, such as raffinose, may be administered at the same time as or separately from the strain.
    Type: Application
    Filed: September 24, 2020
    Publication date: May 11, 2023
    Applicant: PRECISIONBIOTICS GROUP LIMITED
    Inventor: Jens WALTER
  • Publication number: 20210177915
    Abstract: This disclosure describes novel probiotics, and also describes novel methods by which such probiotics can be obtained.
    Type: Application
    Filed: September 2, 2020
    Publication date: June 17, 2021
    Inventors: Jens Walter, Bob Hutkins, Thomas Burkey
  • Publication number: 20190240652
    Abstract: A metering device for controlled receiving and/or dispensing of one or more media, includes one or more pump unit(s) and one or more control units having at least one signal input device configured to record one or more user input(s). The at least one signal input device includes one or more sensor(s) configured to detect the user input(s) and to convert the detected user input(s) into one or more measured value(s). One or more evaluation unit(s) are configured to control the pump unit(s) as a function of the measured value(s). The user input(s) is/are an action of force of a pressure change (?p) effected by a user. In addition, a method for operating the metering device is provided.
    Type: Application
    Filed: April 18, 2019
    Publication date: August 8, 2019
    Inventors: Gerd Bornmann, Jens Walter
  • Publication number: 20180071345
    Abstract: This disclosure describes novel probiotics, and also describes novel methods by which such probiotics can be obtained.
    Type: Application
    Filed: August 24, 2017
    Publication date: March 15, 2018
    Inventors: Jens Walter, Bob Hutkins, Thomas Burkey
  • Patent number: 9125935
    Abstract: This disclosure describes novel probiotics, and also describes novel methods by which such probiotics can be obtained.
    Type: Grant
    Filed: May 31, 2012
    Date of Patent: September 8, 2015
    Assignee: NUtech Ventures
    Inventors: Jens Walter, Bob Hutkins, Thomas Burkey
  • Publication number: 20130288261
    Abstract: This disclosure describes novel probiotics, and also describes novel methods by which such probiotics can be obtained.
    Type: Application
    Filed: June 19, 2013
    Publication date: October 31, 2013
    Inventors: Jens Walter, Bob Hutkins, Thomas Burkey
  • Publication number: 20090178145
    Abstract: The present invention provides methods for identifying genes and proteins that may regulate angiogenesis. The genes identified may be used as markers for the disease onset and progression and to measure efficacy of a therapeutic. The present invention also provides methods to screen agents that are capable of regulating angiogenesis. The present invention also provides methods of identifying therapeutic compounds that may treat various disorders by regulating the expression and activity of genes and proteins identified.
    Type: Application
    Filed: May 10, 2006
    Publication date: July 9, 2009
    Applicant: The Procter & Gamble Company
    Inventors: Andrew Nicholas Carr, Kevin Gene Peters, Claus-Jens Walter Doersen, Xiaoyan Qu